United States · 
Who invested in Origen Therapeutics?
Origen Therapeutics's investors include NIST.
200820092010
$2.0MGrant$3.7MVentureUnited States · Venture startup
Who invested in Origen Therapeutics
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$5.7Mraised across 2 rounds since 2007, from 2 sources
$2.0MGrant$3.7MVenture
- Latest round
- Venture, $3.7MAug 2010
- Step-upi
- 1.9×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Grant, $2.0M Oct 2007
- Biggest round
- $3.7M Venture · Aug 2010
- Between rounds
- 2.8 years from the last two
The rounds
- Aug 2010Venture$3.7M
No investor was named in the report.
From a historical funding record
- Oct 2007
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Origen Therapeutics
How much has Origen Therapeutics raised?
Origen Therapeutics has raised $5.7M across 2 rounds since 2007.
When did Origen Therapeutics last raise?
Origen Therapeutics's most recent round was a Venture of $3.7M in Aug 2010.
What was Origen Therapeutics's biggest round?
Its most recent round, $3.7M in Aug 2010, is also its largest on record.
Who backed Origen Therapeutics first?
Origen Therapeutics's first round on record, in Oct 2007, was backed by NIST.
What stage is Origen Therapeutics at?
Origen Therapeutics's latest named round is a Venture, in Aug 2010.
Where is Origen Therapeutics based?
Origen Therapeutics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.